Morning Overview on MSN
The FDA cleared the first computer-assisted device for pulling clots out of stroke patients
Stroke patients who arrive at a hospital with a large blood clot blocking a major brain artery now have a new treatment ...
Penumbra, Inc. announced the results of the THUNDER investigational device exemption (IDE) study evaluating the safety and ...
THUNDER is a single-arm, prospective, multicenter study with core-lab adjudication to evaluate the safety and effectiveness ...
Penumbra, which is set to become part of Boston Scientific this year, is running the trial to inform the treatment of a type of medium-vessel blockage.
The recent class I recall of a Penumbra cardiac device used in mechanical thrombectomy procedures provides a case study for the shortcomings of the current 510(k) medical device clearance process and ...
MarketBeat on MSN
3 medical device stocks giving investors a different healthcare play
Key Points Interested in Globus Medical, Inc.? Here are five stocks we like better. Globus Medical continues to grow revenue ...
Penumbra said Tuesday it has started a clinical trial that could support wider use of mechanical thrombectomy in a subset of stroke patients. The real-world prospective study is assessing Penumbra's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results